It's far too early to say that the Koronis drug will help cure HIV.

FORBES: Magazine Article

More trials are needed to determine if the Koronis drug can take down HIV in humans.

FORBES: Focus

Scientists at Koronis Pharmaceuticals, a small private biotech company in Seattle, have a drug candidate that does just that.

FORBES: With Koronis, Is A Cure For HIV On The Horizon?

Scientists at Koronis have been able to eradicate HIV in a petri dish.

FORBES: With Koronis, Is A Cure For HIV On The Horizon?

Results from a midstage clinical trial, released in January, showed that the Koronis drug increased the frequency of mutations in the HIV genome by 20%.

FORBES: Focus

Koronis CEO Donald Elmer explains that the Koronis drug uses the viral replication process to induce additional mutations in the HIV genome by mismatch base pairing.

FORBES: With Koronis, Is A Cure For HIV On The Horizon?

Koronis was formed in 1999 after seven years of research by James Mullins and Lawrence Loeb, two professors at the University of Washington, and John Essigmann, a professor at MIT.

FORBES: Focus

More trials have to be done to determine if the Koronis drug can essentially take down the HIV virus, but at least one analyst believes it could be a game changer.

FORBES: With Koronis, Is A Cure For HIV On The Horizon?

One small company in Seattle, Koronis Pharmaceuticals, has even attempted to eradicate HIV by causing the virus to mutate itself out of existence (as researched in a recent Stage IIa trial).

FORBES: Progress in Drug Therapy Marks the 25th Anniversary of World AIDS Day

"Outside the U.S. HIV is still a pandemic, " says Donald Elmer, chief executive of Koronis Pharmaceuticals, a small private biotech firm in Seattle that has come up with what its scientists believe could be a better treatment.

FORBES: Magazine Article